Dr. Kai Pleyer has accumulated 21 years of experience in General Medicine, Rheumatology, and Orthopedics. He is currently working as a Senior Consultant at Oberwart General Hospital, where he specializes in treating musculoskeletal disorders and autoimmune diseases affecting the joints, such as rheumatoid arthritis and lupus. He also works with patients suffering from degenerative joint diseases like osteoarthritis. After completing his medical degree at the Medical University of Vienna, Dr. Pleyer worked in various clinical settings before settling at Oberwart General Hospital. Over the years, he has earned a reputation for his expertise in both clinical management and rehabilitation of orthopedic patients. His work includes integrating non-surgical treatments alongside traditional therapies to improve patient mobility and pain management.
rnMedical University of Vienna (MedUni Vienna)rn · Doctor of Medicine (MD) · Year: 2004
Dr. Pleyer has a strong background in research, particularly in the field of autoimmune diseases and musculoskeletal health. His research focuses on improving treatment modalities for conditions like rheumatoid arthritis, systemic lupus erythematosus, and osteoporosis. Dr. Pleyer has been involved in clinical trials investigating the efficacy of new biologic drugs in autoimmune disease management. His research work has been published in several international journals, and he regularly presents at rheumatology and orthopedic conferences worldwide. His contributions have helped shape modern approaches to managing chronic musculoskeletal conditions and improving long-term outcomes for patients.
Best Rheumatologist of the Year – Oberwart General Hospital, 2021
Outstanding Researcher Award – Medical University of Vienna, 2018
Excellence in Patient Care – Oberwart General Hospital, 2019
Dr. Kai Pleyer has authored several key research papers in the fields of rheumatology and orthopedics, particularly focusing on advancements in the treatment of rheumatoid arthritis and degenerative joint diseases. His research on the efficacy of new biologics in rheumatoid arthritis has been published in The Journal of Rheumatology and has influenced treatment strategies in Europe. Additionally, Dr. Pleyer co-authored a study on bone health in patients with autoimmune disorders, which appeared in The Austrian Journal of Orthopedics and Rheumatology. His work continues to contribute to the medical community’s understanding of these conditions and the best practices for managing them.
Consultation fees are indicative and subject to change.
Consultation fees are indicative and subject to change.
The information on MyHospitalNow is for general informational purposes only and does not constitute medical advice. Consultation fees shown are indicative and subject to change. Always consult a qualified healthcare professional for diagnosis and treatment.